Therefore, as observed in both depression and obesity, disturbances in synaptic plasticity, and cognitive dysfunction may result from changes in the levels or action of both insulin and GLP-1; however, it is unclear whether this effect is due to their direct action or related to their effects on metabolic processes in these regions of the brain. The gene discussed is INS; the disease is depressive symptom measurement.